000			01796 a2200493 4500
005			20250513203143.0
264		0	_c20000321
008			200003s 0 0 eng d
022			_a1784-3286
024	7		_a10.1080/17843286.1999.11754256 _2doi
040			_aNLM _beng _cNLM
100	1		_aBuysschaert, M
245	0	0	_aGlycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes. _h[electronic resource]
260			_bActa clinica Belgica _cDec 1999
300			_a328-33 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Oral
650	0	4	_aAdrenergic beta-Antagonists _xtherapeutic use
650	0	4	_aAged
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aBlood Pressure _xphysiology
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aCohort Studies
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDiabetic Angiopathies _xetiology
650	0	4	_aDiabetic Neuropathies _xetiology
650	0	4	_aDiuretics _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlycated Hemoglobin _xanalysis
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aSulfonylurea Compounds _xtherapeutic use
700	1		_aHermans, M P
773	0		_tActa clinica Belgica _gvol. 54 _gno. 6 _gp. 328-33
856	4	0	_uhttps://doi.org/10.1080/17843286.1999.11754256 _zAvailable from publisher's website
999			_c10640941 _d10640941